Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Bausch Health Companies Inc.

Pharma Giants' Profit Trends: Regeneron vs. Bausch Health

__timestampBausch Health Companies Inc.Regeneron Pharmaceuticals, Inc.
Wednesday, January 1, 201460089000002614539000
Thursday, January 1, 201578538000003711019000
Friday, January 1, 201670630000004560733000
Sunday, January 1, 201761760000005475166000
Monday, January 1, 201860290000006276700000
Tuesday, January 1, 201962510000007081200000
Wednesday, January 1, 202057780000007377200000
Friday, January 1, 2021604000000013634200000
Saturday, January 1, 2022576000000010612500000
Sunday, January 1, 2023619800000011301400000
Monday, January 1, 202412231500000
Loading chart...

Igniting the spark of knowledge

Gross Profit Trends: A Tale of Two Pharmaceutical Giants

In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Regeneron Pharmaceuticals, Inc. and Bausch Health Companies Inc. from 2014 to 2023. Over this period, Regeneron has shown a remarkable growth trajectory, with its gross profit increasing by over 330%, peaking in 2021. In contrast, Bausch Health's profits have remained relatively stable, with minor fluctuations, peaking in 2015. By 2023, Regeneron's gross profit was nearly double that of Bausch Health, highlighting its robust growth strategy. This comparison underscores the dynamic nature of the pharmaceutical sector, where strategic innovation and market adaptation are key to financial success. As the industry continues to evolve, these trends offer valuable insights into the competitive landscape and the financial health of these two major players.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025